The recommended starting dosage and the established effective dosage is 20 mg/day. The maximum dosage should not exceed 60 mg/day.Long-term maintenance of efficacy was demonstrated in a 3‑month relapse prevention trial. Patients in all studies had moderate to severe OCD (DSM‑IIIR) with mean baseline ratings on the Yale Brown Obsessive Compulsive Scale (YBOCS) total score ranging from 23 to 26. As a first-class, certified online pharmacy serving many satisfied customers since 2001, CanadaPharmacy.com is the most trusted name in high-quality, affordable medications. A third study, also flexible-dose comparing paroxetine (20 mg to 50 mg daily), did not demonstrate statistically significant superiority of Paxil over placebo on the Hamilton Rating Scale for Anxiety (HAM‑A) total score, the primary outcome.Subgroup analyses did not indicate differences in treatment outcomes as a function of race or gender. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.The efficacy of Paxil in the treatment of GAD was established in two 8‑week placebo‑controlled trials in adults with GAD. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 or 1-800-332-1088.Keep Paxil and all medicines out of the reach of children.We comply with the HONcode standard for trustworthy health information - Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding. The taper‑phase regimen used in GAD and PTSD clinical trials involved an incremental decrease in the daily dose by 10 mg/day at weekly intervals. This decision can only be made on a case by case basis (see During premarketing testing, hypomania or mania occurred in approximately 1.0% of unipolar patients treated with Paxil compared to 1.1% of active‑control and 0.3% of placebo‑treated unipolar patients. Paroxetine (marketed as Paxil) is included in the class of drugs called selective serotonin reuptake inhibitors (SSRIs). In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered (see In some cases, a patient already receiving therapy with Paxil may require urgent treatment with linezolid or intravenous methylene blue. Patients were dosed in a range of 10 to 60 mg/day in the clinical trials demonstrating the effectiveness of Paxil.
Patients randomized to paroxetine were significantly less likely to relapse than comparably treated patients who were randomized to placebo.Subgroup analyses did not indicate that there were any differences in treatment outcomes as a function of age or gender.The effectiveness of Paxil in the treatment of social anxiety disorder was demonstrated in three 12‑week, multicenter, placebo‑controlled studies (Studies 1, 2, and 3) of adult outpatients with social anxiety disorder (DSM‑IV). In comparison to CParoxetine is extensively metabolized after oral administration. Cart 0 In a subset of patients classified as bipolar, the rate of manic episodes was 2.2% for Paxil and 11.6% for the combined active‑control groups. Missed our announcement yesterday about our $10M commitment over 10 yrs. Adverse experiences, consisting primarily of headache, nausea, sweating, and dizziness, have been reported when tryptophan was administered to patients taking Paxil. Some patients not responding to a 20-mg dose may benefit from dose increases, in 10-mg/day increments, up to a maximum of 50 mg/day. HOW TO ORDER
There was no indication in this study of any additional benefit for doses higher than 20 mg/day.Subgroup analyses generally did not indicate differences in treatment outcomes as a function of age, race, or gender.The effectiveness of Paxil in the treatment of Generalized Anxiety Disorder (GAD) was demonstrated in two 8‑week, multicenter, placebo‑controlled studies (Studies 1 and 2) of adult outpatients with Generalized Anxiety Disorder (DSM‑IV).Study 1 was an 8‑week study comparing fixed paroxetine doses of 20 mg or 40 mg/day with placebo.